Nutrien Ltd. (NTR)
| Market Cap | 34.34B +23.7% |
| Revenue (ttm) | 26.88B +8.6% |
| Net Income | 2.39B +352.9% |
| EPS | 4.93 +363.8% |
| Shares Out | 480.02M |
| PE Ratio | 14.39 |
| Forward PE | 11.42 |
| Dividend | $2.19 (3.06%) |
| Ex-Dividend Date | Jun 30, 2026 |
| Volume | 2,300,696 |
| Open | 70.75 |
| Previous Close | 70.94 |
| Day's Range | 70.39 - 71.63 |
| 52-Week Range | 53.03 - 85.36 |
| Beta | 1.10 |
| Analysts | Buy |
| Price Target | 77.79 (+7.67%) |
| Earnings Date | May 6, 2026 |
About NTR
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment markets crop nutrients, crop protection products, seed, and merchandise, as well as provides agronomic application and financing services and solutions; and produces proprietary products, including proprietary crop nutrient, crop protection, and seed products. The Potash segment includes mining and processing of potash. The Nitrogen segment owns and operates ammonia production facilities that of... [Read more]
Financial Performance
In 2025, Nutrien's revenue was $25.95 billion, an increase of 3.73% compared to the previous year's $25.02 billion. Earnings were $2.27 billion, an increase of 236.35%.
Financial StatementsAnalyst Summary
According to 19 analysts, the average rating for NTR stock is "Buy." The 12-month stock price target is $77.79, which is an increase of 7.67% from the latest price.
News
Nutrien Ltd at BMO Capital Markets Global Farm to Market Conference Transcript
Nutrien Ltd at BMO Capital Markets Global Farm to Market Conference Transcript
Nutrien Transcript: 21st Annual Global Farm to Market Conference
Nutrien Ltd (NTR) Shares Surge 5.3% -- What GF Score of 71 Tells Investors
Nutrien Ltd (NTR) Shares Surge 5.3% -- What GF Score of 71 Tells Investors
Is Nutrien Ltd (NTR) Overvalued After 4.3% Rally? GF Value Says Overvalued
Is Nutrien Ltd (NTR) Overvalued After 4.3% Rally? GF Value Says Overvalued
Nutrien management to meet with Oppenheimer
Meeting to be held on May 14 hosted by Opppenheimer.
Nutrien price target raised to $80 from $75 at Scotiabank
Scotiabank raised the firm’s price target on Nutrien (NTR) to $80 from $75 and keeps a Sector Perform rating on the shares. The firm said it is warming up to…
Nutrien price target lowered to $83 from $86 at TD Securities
TD Securities lowered the firm’s price target on Nutrien (NTR) to $83 from $86 and keeps a Buy rating on the shares post the Q1 report. The firm sees phosphate…
Nutrien price target lowered to $65 from $67 at UBS
UBS lowered the firm’s price target on Nutrien (NTR) to $65 from $67 and keeps a Sell rating on the shares.
Nutrien price target raised to $80 from $78 at JPMorgan
JPMorgan analyst Jeffrey Zekauskas raised the firm’s price target on Nutrien (NTR) to $80 from $78 and keeps an Overweight rating on the shares.
Nutrien Announces Mark Thompson as a Speaker at the BMO Farm to Market Conference
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Nutrien Ltd. (TSX and NYSE: NTR) announced today that Mr. Mark Thompson, Nutrien's Executive Vice President and Chief Financial Officer, will be speaking at t...
Q1 2026 Nutrien Ltd Earnings Call Transcript
Q1 2026 Nutrien Ltd Earnings Call Transcript
Canadian potash producer reports Q1 earnings of US$139M
Nutrien Ltd. reported net earnings of US$139 million during the first quarter, rising from US$19 million during the same period last year.
Investor Outlook: Nutrien upgraded as global crop markets tighten
Nutrien shares slipped after earnings as investors weighed volatile fertilizer prices and improving long-term crop fundamentals.
Nutrien Earnings Call Transcript: Q1 2026
First quarter 2026 saw strong operational and financial performance, with record potash sales, robust retail margins, and higher adjusted EBITDA, despite ongoing Middle East conflict disrupting global fertilizer markets. Strategic reviews and portfolio optimization continue, with guidance and capital allocation unchanged.
Nutrien price target raised to $86 from $81 at TD Securities
TD Securities analyst Michael Tupholme raised the firm’s price target on Nutrien (NTR) to $86 from $81 and keeps a Buy rating on the shares ahead of the Q1 report.
Nutrien reports Q1 adjusted EPS 51c, consensus 54c
Reports Q1 revenue $6.05B, consensus $5.29B. “Nutrien (NTR) delivered record potash sales volumes and stronger Nitrogen and Retail performance in the first quarter. We increased production from our lo...
Nutrien backs FY26 retail adjusted EBITDA view $1.75B-$1.95B
The company said, “Total capital expenditures guidance of $2.0 to $2.1 billion is consistent with 2025 as we continue to optimize capital to sustain safe and reliable operations and to
Nutrien Ltd. Bottom Line Climbs In Q1
(RTTNews) - Nutrien Ltd. (NTR) announced a profit for its first quarter that Increases, from the same period last year
Nutrien (NTR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Nutrien (NTR) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street e...
Nutrien Announces Results of 2026 Annual Meeting
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Nutrien Ltd. (TSX and NYSE: NTR) announced today the results of its annual meeting of shareholders held on May 6, 2026 (the “Meeting”). A total of 366,120,629...
Nutrien Declares Quarterly Dividend of US$0.55 per Share
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Nutrien Ltd. (TSX and NYSE: NTR) announced today that its Board of Directors has declared a quarterly dividend of US$0.55 per share payable on July 17, 2026, ...
Nutrien Reports First Quarter 2026 Results
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Nutrien Ltd. (TSX and NYSE: NTR) announced today its first quarter 2026 results, with net earnings of $139 million ($0.27 diluted net earnings per share). Fir...
Nutrien Transcript: AGM 2026
The meeting covered financial results, board elections, auditor reappointment, and executive compensation, with all proposals approved. No shareholder questions were raised, and forward-looking risks were noted. An upcoming Q1 2026 results call was announced.
Raymond James upgrades Nutrien on improving crop fundamentals
Raymond James upgraded Nutrien (NTR) to Outperform from Market Perform with a price target of $90, up from $74. The firm is seeing early signs of improving crop price fundamentals.
Nutrien upgraded to Outperform from Market Perform at Raymond James
Raymond James analyst Steve Hansen upgraded Nutrien (NTR) to Outperform from Market Perform with a $90 price target